Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 39.18% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.38B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.
Undervalued
The company’s latest PE is 42.39, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.73M shares, decreasing 27.47% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 640.29K shares of this stock.